Back
Oryzon Genomics SA 10K Form
Sell
28
ORYZF
Oryzon Genomics SA
Last Price:
$3.36
Seasonality Move:
-14.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ORYZF News And Ratings
See the #1 stock for the next 7 days that we like better than ORYZF
ORYZF Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.57 |
| Price / Book: | 2.14 |
Profitability
| EPS (TTM): | -0.04390 |
|---|---|
| Net Income (TTM): | $-2.8M |
| Gross Margin: | $-159.8K |
| Return on Equity: | -2.73% |
| Return on Assets: | -2.02% |
Oryzon Genomics SA Earnings Forecast
Key Oryzon Genomics SA Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 5 years.
Oryzon Genomics SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ORYZF |
| Website: | oryzon.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 2.13 |
| Quick Ratio: | 1.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ORYZF Technical Analysis vs Fundamental Analysis
Sell
28
Oryzon Genomics SA (ORYZF)
is a Sell
Is Oryzon Genomics SA a Buy or a Sell?
-
Oryzon Genomics SA stock is rated a SellThe current Oryzon Genomics SA [ORYZF] share price is $3.36. The Score for ORYZF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.